Experimental infection and protection against ... - TI Pharma

General Discussion 235
polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in
vitro and suppresses Plasmodium chabaudi infection in mice. J Clin Invest 1995;
95:2315-2323.
30. Wipasa J, Hirunpetcharat C, Mahakunkijcharoen Y, Xu H, Elliott S, Good MF.
Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii
merozoite surface protein 1 and their antibody-independent protective role in
immunity to blood stage malaria. J Immunol 2002; 169:944-951.
31. McCall MB, Sauerwein RW. Interferon-gamma--central mediator of protective
immune responses against the pre-erythrocytic and blood stage of malaria. J
Leukoc Biol 2010; 88:1131-1143.
32. Pombo DJ, Lawrence G, Hirunpetcharat C et al. Immunity to malaria after
administration of ultra-low doses of red cells infected with Plasmodium
falciparum. Lancet 2002; 360:610-617.
33. Huaman MC, Mullen GE, Long CA, Mahanty S. Plasmodium falciparum apical
membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and
memory T cells. Vaccine 2009; 27:5239-5246.
34. Lal AA, Hughes MA, Oliveira DA et al. Identification of T-cell determinants in
natural immune responses to the Plasmodium falciparum apical membrane
antigen [AMA-1) in an adult population exposed to malaria. Infect Immun 1996;
64:1054-1059.
35. Udhayakumar V, Kariuki S, Kolczack M et al. Longitudinal study of natural
immune responses to the Plasmodium falciparum apical membrane antigen
[AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay
Cohort Project VIII. Am J Trop Med Hyg 2001; 65:100-107.
36. Amante FH, Crewther PE, Anders RF, Good MF. A cryptic T cell epitope on the
apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an
anamnestic antibody response: implications for malaria vaccine design. J
Immunol 1997; 159:5535-5544.
37. Burns JM, Jr., Flaherty PR, Nanavati P, Weidanz WP. Protection against
Plasmodium chabaudi malaria induced by immunization with apical membrane
antigen 1 and merozoite surface protein 1 in the absence of gamma interferon
or interleukin-4. Infect Immun 2004; 72:5605-5612.
38. Xu H, Hodder AN, Yan H, Crewther PE, Anders RF, Good MF. CD4+ T cells acting
independently of antibody contribute to protective immunity to Plasmodium
chabaudi infection after apical membrane antigen 1 immunization. J Immunol
2000; 165:389-396.
39. Dutta S, Haynes JD, Moch JK, Barbosa A, Lanar DE. Invasion-inhibitory
antibodies inhibit proteolytic processing of apical membrane antigen 1 of
Plasmodium falciparum merozoites. Proc Natl Acad Sci U S A 2003; 100:12295-
12300.
40. Silvie O, Franetich JF, Charrin S et al. A role for apical membrane antigen 1
during invasion of hepatocytes by Plasmodium falciparum sporozoites. J Biol
Chem 2004; 279:9490-9496.
41. Casares S, Brumeanu TD, Richie TL. The RTS,S malaria vaccine. Vaccine 2010;
28:4880-4894.